Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ruijin Hospital
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
pathologic verified mature T cell lymphoma,including ALK-negative anaplastic large cell lymphoma,peripherial T cell lymphoma-non specific type,angioimmunoblastic T cell lymphoma,enteropathy associated T cell lymphoma and hepatosplenic T cell lymphoma
SGOT/SGPT no more than 2 times of UNL
serum creatinine no more than 1.5 times of UNL
signed informed consent
You may not be if
woman in pregnancy or lactation
allergic to any intervention drug
insuitable to the study due to severe complication
enrolled to other study during the past 6 months
Clareo Health | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
